project id: TCGA-UVM; case submitter id: TCGA-WC-A888; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.72; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.05; rna integrity number: 7.2; age at index: 76; days to birth: -28117; days to death: 575; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1937; age at diagnosis: 28117; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IIB; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 512.0; icd 10 code: C69.30; last known disease status: not reported; morphology: 8770/3; primary diagnosis: Mixed epithelioid and spindle cell melanoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Choroid; synchronous malignancy: No; tissue or organ of origin: Choroid; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 140; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-WC-A888-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;